Log In
BCIQ
Print this Print this
 

cabiralizumab (FPA008)

  Manage Alerts
Collapse Summary General Information
Company Five Prime Therapeutics Inc.
DescriptionHumanized mAb that inhibits colony-stimulating factor 1 receptor (CSF1R; C-FMS; CD115)
Molecular Target Colony-stimulating factor 1 receptor (CSF1R) (C-FMS) (CD115)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$380.0M

0


 Deals Details
Get a free BioCentury trial today